Valsartan And Hydrochlorothiazide Tablet
Product Images NDC 33342-076

16 FDA label images from Macleods Pharmaceuticals Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 33342-076). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Valsartan Hctz 160 12 5mg 90s Baddi

Valsartan Hctz 160 12 5mg 90s Baddi
Label for Valsartan and Hydrochlorothiazide Tablets, USP 160 mg/12.5 mg, film-coated oral tablets. The label shows the product name, strength, dosage form, and NDC number 33342-075-10. Manufactured by Macleods Pharmaceuticals Ltd in India, distributed by Macleods Pharma USA, Inc. The package contains 90 tablets. Storage instructions and pharmacist dispensing information are also included.*
FDA Label Image

Valsartan Hctz 160 12 5mg 90s Daman

Valsartan Hctz 160 12 5mg 90s Daman
Label for Valsartan and Hydrochlorothiazide Tablets, USP 160 mg/12.5 mg film-coated tablets. The label shows the product name, strength, and dosage form, alongside storage instructions, manufacturer information for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd., and pharmacist dispensing guidance. The package contains 90 tablets.*
FDA Label Image

Valsartan Hctz 160 25mg 90s Baddi

Valsartan Hctz 160 25mg 90s Baddi
Label for Valsartan and Hydrochlorothiazide Tablets USP 160 mg/25 mg, film-coated tablets in a 90-tablet package. Labeler is Macleods Pharmaceuticals Limited, with manufacturing information for Macleods Pharma USA, Inc. The label includes storage instructions and a pharmacist note to dispense with the patient information leaflet.*
FDA Label Image

Valsartan Hctz 160 25mg 90s Daman

Valsartan Hctz 160 25mg 90s Daman
Label for Valsartan and Hydrochlorothiazide Tablets, USP 160 mg/25 mg, film-coated tablets. The label states the dosage strengths, contains storage instructions, and mentions Macleods Pharma USA, Inc. as the manufacturer with Macleods Pharmaceuticals Ltd. (India) also referenced. The package contains 90 tablets for oral use.*
FDA Label Image

Valsartan Hctz 320 12 5mg 90s Baddi

Valsartan Hctz 320 12 5mg 90s Baddi
Label for Valsartan and Hydrochlorothiazide Tablets, USP, 320 mg/12.5 mg film-coated tablets by Macleods Pharmaceuticals Limited. The package contains 90 tablets. It includes storage instructions, manufacturer and labeler details, and a barcode. The label notes prescription-only status and advises dispensing with a patient information leaflet.*
FDA Label Image

Valsartan Hctz 320 12 5mg 90s Daman

Valsartan Hctz 320 12 5mg 90s Daman
Label for Valsartan and Hydrochlorothiazide Tablets, USP, 320 mg/12.5 mg film-coated tablets. The label indicates the product is manufactured by Macleods Pharmaceuticals Limited and Macleods Pharma USA, Inc. The label shows a package size of 90 tablets and includes dosing storage instructions and a direction to see prescribing information for dosage and administration.*
FDA Label Image

Valsartan Hctz 320 25mg 90s Baddi

Valsartan Hctz 320 25mg 90s Baddi
Label for Valsartan and Hydrochlorothiazide Tablets, USP 320 mg/25 mg film-coated tablets by Macleods Pharmaceuticals Limited. The label states the unit contains 90 tablets, manufactured for Macleods Pharma USA, Inc., and includes storage instructions and dispensing information for pharmacists. The label also shows barcodes and manufacturing details in India.*
FDA Label Image

Valsartan Hctz 320 25mg 90s Daman

Valsartan Hctz 320 25mg 90s Daman
Label for Valsartan and Hydrochlorothiazide Tablets, USP 320 mg/25 mg, film-coated oral tablets. The label indicates packaging of 90 tablets from Macleods Pharmaceuticals Limited, manufactured for Macleods Pharma USA, Inc. Dosage storage instructions and NDC 33342-078-10 are also visible on the label.*
FDA Label Image

Valsartan Hctz 80 12 5mg 90s Baddi

Valsartan Hctz 80 12 5mg 90s Baddi
Label for Valsartan and Hydrochlorothiazide Tablets, USP 80 mg/12.5 mg film-coated tablets. The label specifies the product contains 90 tablets and is manufactured by Macleods Pharmaceuticals Ltd. Storage instructions and dosage information references are provided. The label is marked for prescription use only.*
FDA Label Image

Valsartan Hctz 80 12 5mg 90s Daman

Valsartan Hctz 80 12 5mg 90s Daman
Label for Valsartan and Hydrochlorothiazide Tablets, USP 80 mg/12.5 mg film-coated oral tablets by Macleods Pharmaceuticals Limited. The package contains 90 tablets. The label includes storage instructions, dosage reference, manufacturer details, and barcode.*
FDA Label Image

Valsartan Hctz Figure 1

Valsartan Hctz Figure 1
A line chart showing the percentage of patients with systolic blood pressure (SBP) below 140 mmHg across different baseline SBP values ranging from 140 to 180 mmHg. The chart compares four groups: Valsartan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo. Each group's trend is represented with different markers, illustrating treatment efficacy in lowering SBP.*
FDA Label Image

Valsartan Hctz Figure 2

Valsartan Hctz Figure 2
A line graph showing the percentage of patients with diastolic blood pressure less than 90 mmHg (% DBP<90) plotted against baseline diastolic blood pressure (DBP) in mmHg. The graph compares four groups: Valsartan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo, illustrating their effects on DBP.*
FDA Label Image

Valsartan Hctz Figure 3

Valsartan Hctz Figure 3
A line graph depicting the percentage of subjects achieving systolic blood pressure (SBP) below 130 mmHg, plotted against baseline SBP (mmHg). Four treatment groups are compared: Valsartan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo, each represented by different symbols.*
FDA Label Image

Valsartan Hctz Figure 4

Valsartan Hctz Figure 4
A line graph depicting the percentage of subjects achieving a diastolic blood pressure (DBP) below 80 mmHg against baseline DBP values ranging from 90 to 110 mmHg. The graph compares four groups: Valsartan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo, each represented by different markers.*
FDA Label Image

Valsartan Hctz Hydrochlorothiazide

Valsartan Hctz Hydrochlorothiazide
Chemical structure of Valsartan and Hydrochlorothiazide showing the arrangement of atoms including chlorine, sulfur, nitrogen, and oxygen in the molecule.*
FDA Label Image

Valsartan Hctz Valsartan

Valsartan Hctz Valsartan
Chemical structure of the active ingredient Valsartan, showing its molecular formula with various chemical groups including a biphenyl tetrazole ring and a carboxyl group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.